自身免疫性垂体炎：疾病谱更新与研究进展
Autoimmune Hypophysitis: Disease Spectrum Update and Research Progress
DOI: 10.12677/acm.2026.162392, PDF,   
作者: 冯金科, 董 明*：山东大学第一临床学院，山东 济南
关键词: 自身免疫性垂体炎；诊断；治疗；预后；Autoimmune Hypophysitis； Diagnosis； Treatment； Prognosis
摘要: 自身免疫性垂体炎(AH)是一种累及下丘脑–垂体系统的器官特异性罕见疾病。其病理核心为免疫细胞在垂体内的多态性浸润，导致垂体结构与功能不同程度受损。最新研究表明，其发病机制涉及免疫耐受失衡、遗传易感性及肿瘤抗原异位表达等多重因素的共同作用。近年来，随着免疫检查点抑制剂(ICI)的广泛应用与诊断技术的发展，该病的分类体系不断扩展，目前已识别出抗PIT-1垂体炎、ICI相关性垂体炎等多种临床亚型。本综述概述了关于AH的研究背景、发病机制、诊断创新、治疗策略及预后影响因素，有助于了解目前垂体炎的最新进展和未来发展的领域，为临床医生对AH患者的早期识别和逐步治疗提供了相关依据。
Abstract: Autoimmune hypophysitis (AH) is a rare organ-specific disease involving the hypothalamic-pituitary system. Its pathological hallmark is polymorphic infiltration of immune cells within the pituitary gland, leading to varying degrees of structural damage and functional impairment. The recent study shows that its pathogenesis involves a complex interplay of multiple factors, including dysregulated immune tolerance, genetic susceptibility, and ectopic expression of tumor-associated antigens. In recent years, with the widespread use of immune checkpoint inhibitors and advancements in diagnostic technologies, the classification of AH has continuously expanded. Recognized clinical subtypes now include anti-PIT-1 hypophysitis and immune checkpoint inhibitor-associated hypophysitis, among others. This review summarizes the current knowledge on the pathogenesis, diagnostic innovations, therapeutic strategies, and prognostic factors of AH and its emerging subtypes. It highlights the latest advances and outlines future directions in hypophysitis research, aiming to provide clinicians with evidence-based insights to facilitate early recognition and stepwise management of patients with AH.
文章引用：冯金科, 董明. 自身免疫性垂体炎：疾病谱更新与研究进展[J]. 临床医学进展, 2026, 16(2): 295-304. https://doi.org/10.12677/acm.2026.162392

参考文献

[1] Gubbi, S., Hannah-Shmouni, F., Stratakis, C.A. and Koch, C.A. (2018) Primary Hypophysitis and Other Autoimmune Disorders of the Sellar and Suprasellar Regions. Reviews in Endocrine and Metabolic Disorders, 19, 335-347. [Google Scholar] [CrossRef] [PubMed]
[2] 陈忠平, 杜子威, 惠国桢, 等. 自身免疫性垂体炎的病理形态与功能联系[J]. 苏州医学院学报, 1989(2): 93-95, 167-173.
[3] Caturegli, P., Newschaffer, C., Olivi, A., Pomper, M.G., Burger, P.C. and Rose, N.R. (2005) Autoimmune Hypophysitis. Endocrine Reviews, 26, 599-614. [Google Scholar] [CrossRef] [PubMed]
[4] Onyema, M.C., Drakou, E.E. and Dimitriadis, G.K. (2022) Endocrine Abnormality in Paraneoplastic Syndrome. Best Practice & Research Clinical Endocrinology & Metabolism, 36, Article ID: 101621. [Google Scholar] [CrossRef] [PubMed]
[5] Menotti, S., Giampietro, A., Raia, S., Veleno, M., Angelini, F., Tartaglione, T., et al. (2023) Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review. Journal of Personalized Medicine, 13, Article 1210. [Google Scholar] [CrossRef] [PubMed]
[6] Kruse, M., Olesen, T.B., Markovic, L., Glintborg, D. and Andersen, M.S. (2021) Recurrent Autoimmune Hypophysitis Treated with Rituximab: A Case Report. Journal of Medical Case Reports, 15, Article No. 591. [Google Scholar] [CrossRef] [PubMed]
[7] 陈晓依, 陈树春. 2020年日本内分泌学会《自身免疫性垂体炎和IgG4相关性垂体炎的诊断和治疗指南》解析及对我国全科诊疗的启示[J]. 中国全科医学, 2020, 23(36): 4535-4540.
[8] Goudie, R.B. and Pinkerton, P.H. (1962) Anterior Hypophysitis and Hashimoto’s Disease in a Young Woman. The Journal of Pathology and Bacteriology, 83, 584-585. [Google Scholar] [CrossRef] [PubMed]
[9] Miyamoto, M., Sugawa, H., Mori, T., Hashimoto, N. and Imura, H. (1988) A Case of Hypopituitarism Due to Granulomatous and Lymphocytic Adenohypophysitis with Minimal Pituitary Enlargement: A Possible Variant of Lymphocytic Adenohypophysitis. Endocrinologia Japonica, 35, 607-616. [Google Scholar] [CrossRef] [PubMed]
[10] Gubbi, S., Hannah-Shmouni, F., Verbalis, J.G. and Koch, C.A. (2019) Hypophysitis: An Update on the Novel Forms, Diagnosis and Management of Disorders of Pituitary Inflammation. Best Practice & Research Clinical Endocrinology & Metabolism, 33, Article ID: 101371. [Google Scholar] [CrossRef] [PubMed]
[11] Romano, A., Rigante, D. and Cipolla, C. (2019) Autoimmune Phenomena Involving the Pituitary Gland in Children: New Developing Data about Diagnosis and Treatment. Autoimmunity Reviews, 18, Article ID: 102363. [Google Scholar] [CrossRef] [PubMed]
[12] Asa, S.L., Penz, G., Kovacs, K., et al. (1982) Prolactin Cells in the Human Pituitary. A Quantitative Immunocytochemical Analysis. Archives of Pathology & Laboratory Medicine, 106, 360-363.
[13] Elias, K.A. and Weiner, R.I. (1984) Direct Arterial Vascularization of Estrogen-Induced Prolactin-Secreting Anterior Pituitary Tumors. Proceedings of the National Academy of Sciences of the United States of America, 81, 4549-4553. [Google Scholar] [CrossRef] [PubMed]
[14] Atkinson, M. and Lansdown, A.J. (2022) Endocrine Immune-Related Adverse Events: Adrenal, Parathyroid, Diabetes Insipidus, and Lipoatrophy. Best Practice & Research Clinical Endocrinology & Metabolism, 36, Article ID: 101635. [Google Scholar] [CrossRef] [PubMed]
[15] Hrubišková, K., Jackuliak, P., Vaňuga, P., et al. (2010) Autoimunitný polyglandulárny syndróm typ 2 asociovaný s autoimunitnou hypofyzitídou a coeliakiou. Vnitřní lékařství, 56, 1169-1176.
[16] Bellastella, G., Maiorino, M.I., Bizzarro, A., Giugliano, D., Esposito, K., Bellastella, A., et al. (2016) Revisitation of Autoimmune Hypophysitis: Knowledge and Uncertainties on Pathophysiological and Clinical Aspects. Pituitary, 19, 625-642. [Google Scholar] [CrossRef] [PubMed]
[17] Koide, H., Shiga, A., Komai, E., Yamato, A., Fujimoto, M., Tamura, A., et al. (2018) Prednisolone-Responsive Postpartum IgG4-Related Hypophysitis. Internal Medicine, 57, 367-375. [Google Scholar] [CrossRef] [PubMed]
[18] Bernreuther, C., Illies, C., Flitsch, J., Buchfelder, M., Buslei, R., Glatzel, M., et al. (2017) IgG4‐Related Hypophysitis Is Highly Prevalent among Cases of Histologically Confirmed Hypophysitis. Brain Pathology, 27, 839-845. [Google Scholar] [CrossRef] [PubMed]
[19] Vakharia, J.D., Muhammed, M., Remba-Shapiro, I., Marsiglia, M., Hadaway, N., Chwalisz, B.K., et al. (2023) A Novel Approach to Hypophysitis: Outcomes Using Non-Glucocorticoid Immunosuppressive Therapy. European Journal of Endocrinology, 189, 309-317. [Google Scholar] [CrossRef] [PubMed]
[20] 王书畅. 自身免疫性垂体炎的临床诊治及预后研究[D]: [博士学位论文]. 北京: 北京协和医学院, 2017.
[21] Bando, H., Kanie, K. and Takahashi, Y. (2022) Paraneoplastic Autoimmune Hypophysitis: An Emerging Concept. Best Practice & Research Clinical Endocrinology & Metabolism, 36, Article ID: 101601. [Google Scholar] [CrossRef] [PubMed]
[22] Takahashi, Y. (2022) The Novel Concept of “Onco-Immuno-Endocrinology” Led to the Discovery of New Clinical Entity “Paraneoplastic Autoimmune Hypophysitis”. Best Practice & Research Clinical Endocrinology & Metabolism, 36, Article ID: 101663. [Google Scholar] [CrossRef] [PubMed]
[23] Albarel, F., Castinetti, F. and Brue, T. (2019) Management of Endocrine Disease: Immune Check Point Inhibitors-Induced Hypophysitis. European Journal of Endocrinology, 181, R107-R118. [Google Scholar] [CrossRef] [PubMed]
[24] Gutenberg, A., Buslei, R., Fahlbusch, R., Buchfelder, M. and Brück, W. (2005) Immunopathology of Primary Hypophysitis: Implications for Pathogenesis. The American Journal of Surgical Pathology, 29, 329-338. [Google Scholar] [CrossRef] [PubMed]
[25] Chiloiro, S., Capoluongo, E.D., Tartaglione, T., Bianchi, A., Giampietro, A., Angelini, F., et al. (2018) Human Leucocyte Antigens Coeliac Haplotypes and Primary Autoimmune Hypophysitis in Caucasian Patients. Clinical Endocrinology, 88, 692-699. [Google Scholar] [CrossRef] [PubMed]
[26] Huang, H., Chen, Y., Lin, H., Li, Z., Yang, J. and Tzou, S. (2022) Inhibition of IRAK1 Is an Effective Therapy for Autoimmune Hypophysitis in Mice. International Journal of Molecular Sciences, 23, Article 14958. [Google Scholar] [CrossRef] [PubMed]
[27] Sol, B., de Filette, J.M.K., Awada, G., Raeymaeckers, S., Aspeslagh, S., Andreescu, C.E., et al. (2021) Immune Checkpoint Inhibitor Therapy for ACTH-Secreting Pituitary Carcinoma: A New Emerging Treatment? European Journal of Endocrinology, 184, K1-K5. [Google Scholar] [CrossRef] [PubMed]
[28] Bando, H., Iguchi, G., Fukuoka, H., Yamamoto, M., Hidaka-Takeno, R., Okimura, Y., et al. (2014) Involvement of Pit-1-Reactive Cytotoxic T Lymphocytes in Anti-Pit-1 Antibody Syndrome. The Journal of Clinical Endocrinology & Metabolism, 99, E1744-E1749. [Google Scholar] [CrossRef] [PubMed]
[29] Faje, A. (2016) Hypophysitis: Evaluation and Management. Clinical Diabetes and Endocrinology, 2, Article No. 15. [Google Scholar] [CrossRef] [PubMed]
[30] Takahashi, Y. (2020) Mechanisms in Endocrinology: Autoimmune Hypopituitarism: Novel Mechanistic Insights. European Journal of Endocrinology, 182, R59-R66. [Google Scholar] [CrossRef] [PubMed]
[31] Fischer, A., Martínez-Gómez, J.M., Mangana, J., et al. (2022) 18F-FDG PET/CT for Detection of Immunotherapy-Induced Hypophysitis: A Case-Control Study. Clinical Nuclear Medicine, 49, e656-e663.
[32] Caranci, F., Leone, G., Ponsiglione, A., Muto, M., Tortora, F., Muto, M., et al. (2019) Imaging Findings in Hypophysitis: A Review. La Radiologia Medica, 125, 319-328. [Google Scholar] [CrossRef] [PubMed]
[33] Kobayashi, T., Iwama, S., Sugiyama, D., Yasuda, Y., Okuji, T., Ito, M., et al. (2021) Anti-Pituitary Antibodies and Susceptible Human Leukocyte Antigen Alleles as Predictive Biomarkers for Pituitary Dysfunction Induced by Immune Checkpoint Inhibitors. Journal for ImmunoTherapy of Cancer, 9, e002493. [Google Scholar] [CrossRef] [PubMed]
[34] Joshi, M.N., Whitelaw, B.C. and Carroll, P.V. (2018) Mechanisms in Endocrinology: Hypophysitis: Diagnosis and Treatment. European Journal of Endocrinology, 179, R151-R163. [Google Scholar] [CrossRef] [PubMed]
[35] Urai, S., Iguchi, G., Kanie, K., Bando, H., Yamamoto, M., Oi, Y., et al. (2023) Clinical Features of Anti-Pituitary-Specific Transcription Factor-1 (PIT-1) Hypophysitis: A New Aspect of Paraneoplastic Autoimmune Condition. European Journal of Endocrinology, 190, K1-K7. [Google Scholar] [CrossRef] [PubMed]
[36] Xie, Z., Wang, Q. and Lu, X. (2019) Endoscopic Endonasal Resection of Nonfunctioning Pituitary Adenoma with Radiological Calcification. Pituitary, 22, 381-386. [Google Scholar] [CrossRef] [PubMed]
[37] Pal, R., Chatterjee, D., Singla, R., Jain, N., Bhansali, A. and Dutta, P. (2020) Co-Occurrence of Craniopharyngioma and IgG4-Related Hypophysitis: An Epiphenomenon or a Mere Coincidence? World Neurosurgery, 136, 193-197. [Google Scholar] [CrossRef] [PubMed]
[38] Mark, I.T. and Glastonbury, C.M. (2023) MR Imaging Appearance of Ruptured Rathke Cleft Cyst and Associated Bone Marrow Enhancement. American Journal of Neuroradiology, 44, 1314-1317. [Google Scholar] [CrossRef] [PubMed]
[39] Himes, B.T., Bhargav, A.G., Brown, D.A., Kaufmann, T.J., Bancos, I. and Van Gompel, J.J. (2020) Does Pituitary Compression/Empty Sella Syndrome Contribute to MRI-Negative Cushing’s Disease? A Single-Institution Experience. Neurosurgical Focus, 48, E3. [Google Scholar] [CrossRef] [PubMed]
[40] Behera, K.K., Jena, R.K., Sahoo, S.K. and Soren, U.K. (2021) Complete Resolution of the Pituitary Mass Lesion and Improvement of Pituitary Function with Corticosteroid in Autoimmune Hypophysitis: A Case Report. Ethiopian Journal of Health Sciences, 31, 1069-1072. [Google Scholar] [CrossRef] [PubMed]
[41] Krishnappa, B., Shah, R., Memon, S.S., Diwaker, C., Lila, A.R., Patil, V.A., et al. (2023) Glucocorticoid Therapy as First-Line Treatment in Primary Hypophysitis: A Systematic Review and Individual Patient Data Meta-Analysis. Endocrine Connections, 12, e220311. [Google Scholar] [CrossRef] [PubMed]
[42] Lupi, I., Cosottini, M., Caturegli, P., Manetti, L., Urbani, C., Cappellani, D., et al. (2017) Diabetes Insipidus Is an Unfavorable Prognostic Factor for Response to Glucocorticoids in Patients with Autoimmune Hypophysitis. European Journal of Endocrinology, 177, 127-135. [Google Scholar] [CrossRef] [PubMed]
[43] Roujeau, J. (1996) Pulse Glucocorticoid Therapy: The ‘Big Shot’ Revisited. Archives of Dermatology, 132, 1499-1502. [Google Scholar] [CrossRef] [PubMed]
[44] 魏茜. 原发性淋巴细胞性垂体炎诊治与预后分析[D]: [硕士学位论文]. 北京: 中国人民解放军医学院, 2018.
[45] Ray, D.K., Yen, C.P., Vance, M.L., Laws, E.R., Lopes, B. and Sheehan, J.P. (2010) Gamma Knife Surgery for Lymphocytic Hypophysitis: Case Report. Journal of Neurosurgery, 112, 118-121. [Google Scholar] [CrossRef] [PubMed]
[46] Cemeroglu, A.P., Blaivas, M., Muraszko, K.M., Robertson, P.L. and Vázquez, D.M. (1997) Lymphocytic Hypophysitis Presenting with Diabetes Insipidus in a 14-Year-Old Girl: Case Report and Review of the Literature. European Journal of Pediatrics, 156, 684-688. [Google Scholar] [CrossRef] [PubMed]
[47] Faje, A., Reynolds, K., Zubiri, L., Lawrence, D., Cohen, J.V., Sullivan, R.J., et al. (2019) Hypophysitis Secondary to Nivolumab and Pembrolizumab Is a Clinical Entity Distinct from Ipilimumab-Associated Hypophysitis. European Journal of Endocrinology, 181, 211-219. [Google Scholar] [CrossRef] [PubMed]
[48] Chiloiro, S., Tartaglione, T., Capoluongo, E.D., Angelini, F., Arena, V., Giampietro, A., et al. (2018) Hypophysitis Outcome and Factors Predicting Responsiveness to Glucocorticoid Therapy: A Prospective and Double-Arm Study. The Journal of Clinical Endocrinology & Metabolism, 103, 3877-3889. [Google Scholar] [CrossRef] [PubMed]
[49] Chamorro-Pareja, N., Faje, A.T. and Miller, K.K. (2024) Pituitary Complications of Checkpoint Inhibitor Use. Endocrinology, 165, bqae084. [Google Scholar] [CrossRef] [PubMed]
[50] Nishi, N., Takeshima, K., Morita, S., Iwakura, H., Nishi, M. and Matsuoka, T. (2021) Deterioration of Pituitary Function without Relapse after Steroid Therapy for IgG4-Related Hypophysitis. Endocrinology, Diabetes & Metabolism Case Reports, 2021, Article ID: 21-0029. [Google Scholar] [CrossRef] [PubMed]
[51] Takagi, H., Iwama, S., Sugimura, Y., Takahashi, Y., Oki, Y., Akamizu, T., et al. (2020) Diagnosis and Treatment of Autoimmune and IgG4-Related Hypophysitis: Clinical Guidelines of the Japan Endocrine Society. Endocrine Journal, 67, 373-378. [Google Scholar] [CrossRef] [PubMed]
[52] Kanie, K., Bando, H., Iguchi, G., Shiomi, H., Masuda, A., Fukuoka, H., et al. (2019) IgG4-Related Hypophysitis in Patients with Autoimmune Pancreatitis. Pituitary, 22, 54-61. [Google Scholar] [CrossRef] [PubMed]
[53] Chiloiro, S., Tartaglione, T., Angelini, F., Bianchi, A., Arena, V., Giampietro, A., et al. (2016) An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Prospective Single-Center Experience. Neuroendocrinology, 104, 280-290. [Google Scholar] [CrossRef] [PubMed]
[54] Chalan, P., Thomas, N. and Caturegli, P. (2021) Th17 Cells Contribute to the Pathology of Autoimmune Hypophysitis. The Journal of Immunology, 206, 2536-2543. [Google Scholar] [CrossRef] [PubMed]
[55] Angelousi, A., Chatzellis, E. and Kaltsas, G. (2017) New Molecular, Biological, and Immunological Agents Inducing Hypophysitis. Neuroendocrinology, 106, 89-100. [Google Scholar] [CrossRef] [PubMed]
[56] Asada, T., Takenoshita, S., Senda, M., Yamamoto, K., Sasaki, R., Otsuka, F., et al. (2022) Secondary Autoimmune Hypothalamitis with Severe Memory Impairment 7 Years after the Onset of Diabetes Insipidus Due to Lymphocytic Hypophysitis: A Case Report. BMC Neurology, 22, Article No. 371. [Google Scholar] [CrossRef] [PubMed]
[57] Iwama, S. and Arima, H. (2020) Anti-Pituitary Antibodies as a Marker of Autoimmunity in Pituitary Glands. Endocrine Journal, 67, 1077-1083. [Google Scholar] [CrossRef] [PubMed]
[58] Yamamoto, M., Iguchi, G., Bando, H., Kanie, K., Hidaka-Takeno, R., Fukuoka, H., et al. (2019) Autoimmune Pituitary Disease: New Concepts with Clinical Implications. Endocrine Reviews, 41, 261-272. [Google Scholar] [CrossRef] [PubMed]
[59] Mizukoshi, T., Fukuoka, H. and Takahashi, Y. (2022) Immune Checkpoint Inhibitor-Related Hypophysitis. Best Practice & Research Clinical Endocrinology & Metabolism, 36, Article ID: 101668. [Google Scholar] [CrossRef] [PubMed]
[60] Malikova, H., Holesta, M., Fialova, A., et al. (2018) Hypophysitis and Other Autoimmune Complications Related to Immune Check-Points Inhibitors Treatment: Spectrum of Imaging Appearances. Neuro Endocrinology Letters, 39, 196-204.

为你推荐